Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Pharmaceutical approval update.
Multiple sclerosis and pregnancy prescriptions.
Endocannabinoid signalling and the deteriorating brain.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
High-resolution myelin water imaging in post-mortem multiple sclerosis spinal cord: A case report.
Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis.
Microglia: A Unique Versatile Cell in the Central Nervous System.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Tolerogenic vaccines for Multiple sclerosis.
Concomitant neuromyelitis optica and cytomegalovirus-associated retinitis in an immunocompetent female.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Subcutaneous vs intravenous administration of immunoglobulin in chronic inflammatory demyelinating polyneuropathy: an Italian cost-minimization analysis.
Fast computation of myelin maps from MRI T2 relaxation data using multicore CPU and graphics card parallelization.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Microglia play a major role in direct viral-induced demyelination.
Sodium ((23)Na) ultra-short echo time imaging in the human brain using a 3D-Cones trajectory.
Regional brain atrophy and functional connectivity changes related to fatigue in multiple sclerosis.
Noise robust spatially regularized myelin water fraction mapping with the intrinsic B1 -error correction based on the linearized version of the extended phase graph model.
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
[Demyelinating diseases in children with acute neurological symptoms].
New EMA Advice for PML Prevention With Fingolimod in MS
Corticosteroids for treating optic neuritis.
Pages
« first
‹ previous
…
585
586
587
588
589
590
591
592
593
…
next ›
last »